Congress Park Capital’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.64M | Buy |
|
|||||
|
2025
Q2 | $4.7M | Buy |
|
|||||
|
2025
Q1 | $4.48M | Sell |
|
|||||
|
2024
Q4 | $3.76M | Buy |
|
|||||
|
2024
Q3 | $3.94M | Buy |
|
|||||
|
2024
Q2 | $5.52M | Sell |
|
|||||
|
2024
Q1 | $4.56M | Sell |
|
|||||
|
2023
Q4 | $3.06M | Buy |
|
|||||
|
2023
Q3 | $607K | Buy |
|
|||||
|
2023
Q2 | $593K | Buy |
|
|||||
|
2023
Q1 | $484K | Buy |
|
|||||
|
2022
Q4 | $650K | Buy |
|
|||||
|
2022
Q3 | $721K | Buy |
|
|||||
|
2022
Q2 | $447K | Buy |
|
|||||
|
2022
Q1 | $731K | Buy |
|
|||||
|
2021
Q4 | $818K | Sell |
|
|||||
|
2021
Q3 | $1.28M | Sell |
|
|||||
|
2021
Q2 | $3.05M | Buy |
|
|||||
|
2021
Q1 | $3.12M | Sell |
|
|||||
|
2020
Q4 | $4.18M | Sell |
|
|||||
|
2020
Q3 | $3.04M | Buy |
|
|||||
|
2020
Q2 | $2.95M | Buy |
|
|||||
|
2020
Q1 | $1.3M | Sell |
|
|||||
|
2019
Q4 | $2.66M | Buy |
|
|||||
|
2019
Q3 | $2.06M | Buy |
|
|||||
|
2019
Q2 | $1.95M | Buy |
|
|||||
|
2019
Q1 | $1.24M | Buy |
|
|||||
|
2018
Q4 | $1.21M | Buy |
|
|||||
|
2018
Q3 | $1.11M | Sell |
|
|||||
|
2018
Q2 | $1.37M | Sell |
|
|||||
|
2018
Q1 | $1.08M | Sell |
|
|||||
|
2017
Q4 | $844K | Buy |
|